Physician profile
Devprakash Samuel
NPI 1760579171
$6,622.02
in general payments reported to CMS, 2019-2025
43 companies · $939 in 2025
The $939 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $646 · 2020: $73.01 · 2021: $1,070 · 2022: $1,340 · 2023: $1,123 · 2024: $1,431 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,470 · Education: $22.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,469.82 |
| Education | $22.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,674.85 | 2019-2025 | Nayzilam, Briviact, Fintepla |
| Emd Serono, INC. | $780.91 | 2019-2025 | Mavenclad, Mavenclad |
| Biogen, INC. | $417.96 | 2019-2025 | Vumerity, Tysabri |
| Neurelis, INC. | $409.04 | 2021-2025 | Valtoco |
| Abbvie INC. | $301.71 | 2022-2025 | |
| Celgene Corporation | $285.83 | 2021-2024 | Zeposia |
| Eisai INC. | $255.20 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $232.17 | 2021-2022 | |
| Genzyme Corporation | $214.08 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $204.44 | 2019-2025 | Ultomiris |
| Janssen Pharmaceuticals, INC | $185.30 | 2021-2022 | |
| Lilly USA, LLC | $153.54 | 2021-2025 | Emgality, Reyvow, Amyvid |
| Novartis Pharmaceuticals Corporation | $150.93 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $106.61 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $105.58 | 2019-2024 | Austedo Xr |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devprakash Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.